Status:
RECRUITING
2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
Dry Eye Disease
oGVHD
Eligibility:
All Genders
18+ years
Brief Summary
Evaluate and study the immunologic changes to the ocular surface in cancer patients.
Detailed Description
This is a longitudinal natural history study to evaluate and study the immunologic changes to the ocular surface in cancer patients. Two groups of subjects will be recruited for the study: 1) Pre-bon...
Eligibility Criteria
Inclusion Criteria:
- Adult patients (≥ 18 years of age) who visit the Eye clinic either in the UMGCCC within the UMD Hospital or the UMD Faculty Physicians Ophthalmology Practice at the UMD Professional Building or satellite locations for initial visits or established visits.
- The patient must be able to understand and sign and date the informed consent form approved by the IRB.
Exclusion Criteria:
- Vulnerable populations: neonates, children, prisoners, institutionalized individuals.
- Inability or refusal to provide informed consent.
- History of ocular surgery (except refractive surgery or cataract surgery)
Key Trial Info
Start Date :
April 27 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04946721
Start Date
April 27 2022
End Date
December 31 2027
Last Update
February 3 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geenebaum Cancer Center, University of Maryland Medical Center
Baltimore, Maryland, United States, 21201